ASCO 2022 Conference Coverage


 

Lecture Summary - ASCO 2022 Bendamustine Rituximab vs. Ibrutinib as Primary Therapy for WM: An International Collaborative Study

102 views
June 9, 2022
Comments 0
Login to view comments. Click here to Login